Introduction 32
Cells and organelles are defined by lipid bilayer membranes and membrane proteins. 33
Eukaryotic membranes of the secretory/endocytic pathways are typically asymmetric with 34 respect to lipid distribution in the inner and outer bilayer leaflets. The resulting gradients in 35 lipid concentration potentiate important biological processes such as membrane dynamics in 36 morphological changes and motility of the cell, endo-and exocytosis, and signalling [1] [2] [3] [4] . Due to 37 membrane-fusion events and the activity of lipid scramblases, which move lipids between the 38 inner and outer leaflet in both directions, lipid asymmetry must constantly be regulated and 39 couple their lipid flippase activity to dephosphorylation of the E2P state 5, 6 , i.e. similar to the 47 inward K + transport of Na,K-ATPase, whereas E1P phosphoenzyme formation seems 48 independent of substrate binding 6, 7 . While recent studies have shed light on the structure and 49 function of lipid floppases 8, 9 and scramblases 10,11 , P4-ATPases have so far been studied only 50 by bioinformatics and functional assays. To date, the transport mechanism remains enigmatic 51 and is much debated, with models implicating either peripheral or centrally located lipid 52 recognition sites and pathways [12] [13] [14] . 53 54 Most P4-ATPases are binary complexes, where a Cdc50-protein subunit is necessary for proper 55 localization of the complex and probably also for function 15, 16 . Mutant forms of mammalian 56 lipid flippases have been implicated in disease, e.g. ATP8A1 and ATP8A2 in neurological 57 disorders, ATP8B1 in progressive familial intrahepatic cholestasis type 1 (PFIC1), ATP10A in 58 type 2 diabetes and insulin resistance, and ATP11A in cancer 17 . One of the best-characterized 59 P4-ATPases is the trans-Golgi localized Drs2p-Cdc50p complex from the yeast 60
Saccharomyces cerevisiae. In vivo 18, 19 and in vitro 20,21 studies show that Drs2p-Cdc50p 61 primarily flips phosphatidylserine (PS) and to a lesser extent phosphatidylethanolamine (PE) 62 from the lumenal to the cytosolic leaflet, and indicate a role of this function in vesicle 63 biogenesis at late secretory membranes. 64
The C-terminus of Drs2p contains an auto-inhibitory domain 22, 23 . Relief of auto-inhibition 66 requires the regulatory, but non-substrate lipid phosphatidylinositol 4-phosphate (PI4P) 5, 22 . 67
Binding of Gea2p (a guanine nucleotide exchange factor for the small GTPase Arf) to a basic 68 segment of the C-terminus has been reported to be necessary for activation in vivo 22 , although 69 this is not supported by studies in vitro 23 . Furthermore, interaction of Arl1p (another GTPase 70 of the Arf family) with the extended N-terminus of Drs2p has been implicated in flippase 71 activity in vivo 24 . Whereas the first 104 amino acids of the N-terminus have little effect on in 72 vitro activity, truncation of the C-terminus has a strong activating effect, but the protein 73 remains under regulation by PI4P 25 . While these studies highlight the components involved, 74 the detailed molecular mechanism of autoregulation for Drs2p-Cdc50p and for P-type 75
ATPases, in general, remains unknown. 76
77
To determine the structure of a P4-ATPase lipid flippase and investigate the molecular 78 mechanism of transport and autoregulation, we embarked on cryo-EM studies of the beryllium 79 fluoride (BeF3 -) stabilized Drs2p-Cdc50p complex. Drs2p-Cdc50p was over-expressed in S. 80 cerevisiae and purified in the detergent LMNG by affinity chromatography and gel filtration, 81 resulting in a monodisperse sample containing both subunits (Supplementary Data Figure 1 The structure of the Drs2p subunit is typical of P-type ATPases with a transmembrane domain 95 consisting of 10 helices, and three cytosolic domains: the actuator (A) domain, the nucleotide-96 binding (N) domain and the phosphorylation (P) domain ( Figure 1A 
BeF3
-and bound Mg 2+ is readily observable ( Figure 2B ). The conformation of the 152 dephosphorylation loops are similar ( Figure 2C ). Compared to the ion-transporting P-type 153 ATPases, TM1 and 2 appear to be one turn shorter at the lumenal side, suggesting they sit 154 deeper in the membrane. 155
156

Autoinhibition and PI4P binding 157
We were able to map three distinct intermediate states leading from autoinhibition to activation 158 by variations of sample lipids and inhibitors and using constructs containing intact and 159 truncated C-terminal tails. In E2P inhib , the autoinhibitory C-terminus forms an extensive 160 interface that spans 56 residues (residues 1252-1307) along the P-and N-domains, reaching 161 the A-domain ( Figure 3A) . A short helical segment of the C-terminal tail (H1 C-tail , residues 162 1252-1263) interacts with a unique helical insertion on the P-domain, while the rest of the tail 163 extends to interact with the N-and A-domains overlapping with the nucleotide binding site TM1 and in particular TM2, extending directly into the A-domain, moves away from the bulk 217 of the TM domain and exposes TM4 to the lumenal leaflet of the membrane. Consistently, the 218 conserved, unwound segment of TM4 (PISL), which is exposed by this movement, has been 219 implicated in lipid transport 14 ( Figure 5A -B). The lumenal opening towards TM4 is lined by 220 TM1, 2, and 6, and we propose that the cleft marks the entry of a substrate lipid transport 221 pathway. The cleft partially overlaps with a previously proposed entry gate and residues 222 important for lipid specificity 12 . In particular Gln237, part of a conserved QQ-motif at the end 223 of TM1, points into the open cleft, supporting its role in substrate specificity ( Figure 5C ). The 224 cleft is also consistent with the proposed hydrophobic gate model 7 with a central role for the 225 conserved isoleucine of the PISL motif 14 , although the conformation of TM1-2 in E2P active (and 226 the other E2P sub-states reported here) and earlier homology models are different. 227
Interestingly, while the putative lipid entry pathway is reminiscent of that described for 228 scramblases 10,34 , it does not extend to span both leaflets of the membrane, thus highlighting a 229 fundamental requirement for an alternating access mechanism of lipid movement against its 230 gradient. 231 
Transport mechanism 255
The respective orientation and positions for the P and N domains of Drs2p are largely invariable 256 in transition from a constrained E2P inhib to the E2P inter and E2P active states. A rigid body 257 movement of those domains relative to the membrane together with a progressive rotation of 258 the A-domain is apparent from an alignment on TM7-10 ( Figure 5E ). This rigid body 259 movement is also echoed in a concomitant movement of the adjacent TM6-7 loop towards the 260 amphipathic helix formed upon PI4P binding ( Figure 5F ). Interestingly, the position of the 261 dephosphorylation loop remains constant with respect to the P-domain ( Figure 2C ). This 262 suggests that binding of PI4P leads to the movement of the P-domain. The subsequent removal 263 of the C-terminus would allow for increased mobility of the A-domain, which would explain 264 why PI4P alone is not sufficient for full activation of the intact enzyme. and cytoplasmic release will be required to further elucidate the lipid flippase mechanism. * number in parenthesis corresponds to the final range/number. 676 # The B-factor listed is the one used for refinement, while the one in the parentheses is the B-677 factor estimated by Relion PostProcessing. 678
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Enzyme-coupled assay 682
Expression and streptavidin purification of wild-type Drs2p-Cdc50p and mutants for functional 683 studies were carried out as described previously 20, 48 . Specifically, we used for this purpose a 684 C-terminal Tobacco Etch Virus (TEV)-cleavable BAD tag and DDM was used throughout the 685 purification procedure. Size-exclusion chromatography was performed on a Superdex 200 686
Increase 10/300GL column, with a mobile phase containing 0.5 mg.mL -1 DDM and 0.025 687 mg.mL -1 POPS. The rate of ATP hydrolysis by PI4P-binding mutants was measured at 30 °C 688 using an enzyme-coupled assay, by continuously monitoring the rate of NADH oxidation at 689 340 nm 49 . The purified Drs2p-Cdc50p complexes were added at about 2 µg.mL -1 , in a cuvette 690
containing SSR buffer supplemented with 1 mM ATP, 1 mM phosphoenolpyruvate, 0.4 691 mg.mL -1 pyruvate kinase, 0.1 mg.mL -1 lactate dehydrogenase, 0.25 mM NADH, 1 mM NaN3, 692 1 mg.mL -1 DDM, and 0.1 mg. 
